U.S. market Closed. Opens in 18 hours 24 minutes

FMTX | Forma Therapeutics Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/A100.56M164.09M
Cost of RevenueN/AN/AN/AN/A
Gross ProfitN/AN/A100.56M164.09M
Operating Expenses173.99M124.15M135.72M154.40M
Selling, General & Admin48.33M30.78M24.40M21.54M
Research & Development125.66M93.37M111.31M132.86M
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-172.81M-124.21M-40.45M9.69M
Other Expenses / Income172.96M24.08M3.81M4.17M
Before Tax Income-172.81M-100.13M-36.64M13.86M
Income Tax Expenses154.00K-29.72M-1.85M8.57M
Net Income-172.96M-70.41M-34.79M5.29M
Interest ExpensesN/AN/AN/AN/A
Basic Shares Outstanding41.09M23.06M11.37M11.37M
Diluted Shares Outstanding41.09M23.06M11.37M11.37M
EBITDA-171.24M-98.86M-33.97M17.39M
EBITDA Margin0.00%0.00%-33.78%10.60%
EBIT-172.81M-100.13M-36.64M13.86M
EBIT Margin0.00%0.00%-36.44%8.45%
Financial Year End2021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙